- Source: Ponazuril
Ponazuril (INN), sold by Merial, Inc., now part of Boehringer Ingelheim, under the trade name Marquis® (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by coccidia Sarcocystis neurona. Veterinarians have been preparing a formulary version of the medication for use in small animals such as cats, dogs, and rabbits against coccidia as an intestinal parasite. Coccidia treatment in small animals is far shorter than treatment for EPM. Along with its analogue ACD856, ponazuril (also known as ACD855) is a positive allosteric modulator of the tropomyosin receptor kinases TrkA and TrkB.
See also
Clazuril
Diclazuril
Toltrazuril
References
Kata Kunci Pencarian:
- Ponazuril
- Coccidiostat
- Marquis (disambiguation)
- ACD856
- Coccidia
- Diclazuril
- Equine protozoal myeloencephalitis
- List of veterinary drugs
- Clazuril
- Tropomyosin receptor kinase B
